贝兰他单抗
Anti-Human BCMA Monoclonal Antibody(Belantamab biosimilar) mAb; GSK2857914
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$720.00
Member price
Product Availability
3-5days
Price
$1600.00
Member price
Product Availability
3-5days
Price
$2800.00
Member price
Product Availability
3-5days
Price
$13000.00
Member price
Product Availability
3-5days
Price
$20000.00
Member price
Quantity
- +
Product Overview
Product Name Anti-Human BCMA Monoclonal Antibody(Belantamab biosimilar) mAb; GSK2857914
CAS2061894-48-0
Storage conditionSealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles
Security information
Product details

Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD.

Related literature
Related
Sorry, no related items
History
Anti-Human BCMA Monoclonal Antibody(Belantamab biosimilar) mAb; GSK2857914
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372)
Aducanumab (Anti-Amyloid-β )
Diridavumab
Conatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)
Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))
Tabalumab (Anti-TNFSF13B / BAFF / CD257)
Parsatuzumab (Anti-EGFL7)
Placulumab